U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H11BO8
Molecular Weight 221.958
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BORON GLUCONATE

SMILES

OC[C@H]1OB(O)O[C@H]1[C@H](O)[C@@H](O)C(O)=O

InChI

InChIKey=KJEUMRLAKARHEP-TXICZTDVSA-N
InChI=1S/C6H11BO8/c8-1-2-5(15-7(13)14-2)3(9)4(10)6(11)12/h2-5,8-10,13H,1H2,(H,11,12)/t2-,3-,4-,5-/m1/s1

HIDE SMILES / InChI
Molecular Formula C6H11BO8
Molecular Weight 221.958
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://books.google.ru/books?id=Sfmc-fRCj10C&pg=PA58

Boron gluconate is a boron-containing dietary supplement. Calcium salt of boron gluconate is used as a calcium supplement in veterinary to treat hypocalcemia (also called parturient paresis and commonly called milk fever) in cattle, sheep, and goat.

Originator

Hayden, C.E.
2
Curator's Comment: Hayden, C. E. (1934). A Method of Making Concentrated Calcium Gluconate Solutions. Cornell Vet, 24, 93.

Approval Year

2009
359
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Approved
8429
CALJECT

Approved Use

Calcium salt of boron gluconate is used as a calcium supplement in veterinary to treat hypocalcemia (also called parturient paresis and commonly called milk fever) in cattle, sheep, and goat.
PubMed

PubMed

TitleDatePubMed
Cell cycle arrest, extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy.
2013 Jun
Patents

Patents

03932650
2
03935280
4
03939155
33
03944672
2
03947408
15
03966766
4
03970683
4
03987200
9
03994941
6
03996159
2
03996374
5
04011243
2
04012413
6
04018893
2
04053596
2
04062670
2
04065473
2
04077978
5
04081549
2
04089855
2
04090027
9
04090861
2
04093736
2
04102888
8
04115424
2
04122034
2
04138497
6
04139403
3
04140726
2
04146718
6
04153719
2
04153721
2
04165372
7
04168269
3
04171359
2
04171371
2
04172945
10
04178293
2
04178387
13
04180522
5
04185115
2
04189598
2
04208337
2
04208425
2
04210590
2
04211783
5
04217302
2
04220775
6
04220795
2
04228093
3
04238505
2

Sample Use Guides

In Vivo Use Guide
For treatment of hypocalcemia, calcium borogluconate is administered at 1 ml/kg (intravenous, intramuscular, or subcutaneous).
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:59:39 GMT 2023
Edited
by admin
on Fri Dec 15 15:59:39 GMT 2023
Record UNII
X8P2SY4Y7V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BORON GLUCONATE
Common Name English
Borogluconate [WHO-DD]
Common Name English
BORICUM GLUCONICUM
Common Name English
BOROGLUCONATE
Common Name English
Code System Code Type Description
RXCUI
1370421
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
ALTERNATIVE
DAILYMED
X8P2SY4Y7V
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
EPA CompTox
DTXSID001018983
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
RXCUI
259357
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
CAS
87-46-7
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
FDA UNII
X8P2SY4Y7V
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
PUBCHEM
73415777
Created by admin on Fri Dec 15 15:59:39 GMT 2023 , Edited by admin on Fri Dec 15 15:59:39 GMT 2023
PRIMARY
Related Record Type Details
Structure of CALCIUM BOROGLUCONATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of BORON
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966